Maram's PhD research focuses on developing novel treatment strategies for glioblastoma, one of Australia's most aggressive brain cancers, with a five-year survival rate of less than 5%. Specifically, her work investigates Targeted Alpha Therapy (TAT) delivered via convection-enhanced delivery, using advanced Monte Carlo computer simulations (TOPAS) to model how effectively TAT destroys glioblastoma cells and whether combining it with conventional radiotherapy and chemotherapy produces better outcomes. Her research aims to provide the radiobiological evidence base needed to move TAT toward clinical trials, offering patients a more effective treatment for this devastating disease.